Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v27-FR Version v16-EN
Language French English
Date Updated 2020-09-30 2020-07-31
Drug Identification Number 02434539 02434539
Brand name MYLAN-CINACALCET MYLAN-CINACALCET
Common or Proper name CINACALCET CINACALCET
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients CINACALCET CINACALCET
Strength(s) 30MG 30MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30BT 30BT
ATC code H05BX H05BX
ATC description ANTI-PARATHYROID HORMONES ANTI-PARATHYROID HORMONES
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2020-07-22 2020-07-22
Actual start date 2020-07-23 2020-07-23
Estimated end date 2020-09-29 2020-10-27
Actual end date 2020-09-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments